Last updated: September 29, 2025
Introduction
South Korea’s patent system emphasizes robust protection for innovative pharmaceuticals, reflecting its strategic aim to foster local drug development and attract foreign investment. Patent KR20110050709, granted by the Korean Intellectual Property Office (KIPO), focuses on a specific medicinal compound or formulation. Here, we analyze its scope, claims, and the broader patent landscape to understand its strategic relevance and potential competitive impact.
Patent Overview
- Patent Number: KR20110050709
- Grant Date: May 2011
- Assignee: Typically, such patents are held by biotechnology or pharmaceutical companies; the specific assignee details are accessible through KIPO records.
- Field: The patent pertains to a novel pharmaceutical compound, formulation, or method of treatment, often for diseases such as cancer, metabolic disorders, or infectious diseases.
Scope and Core Claims Analysis
1. Patent Scope
The patent’s scope encompasses a specific chemical entity, its salts, derivatives, or a unique formulation thereof. It may also cover methods of synthesizing the compound or employing it for therapeutic purposes. The scope is generally framed to prevent others from manufacturing, using, or selling the claimed compounds or treatments without authorization.
In Korean patent practice, claim breadth critically influences enforceability and commercial value. Broad claims typically define the core compound or method, while narrower claims specify particular derivatives or methods.
2. Claims Breakdown
The key claims generally can be categorized as follows:
-
Compound Claims:
These specify the chemical structure, often represented by a chemical formula, and may include pharmacologically active derivatives or salts. This defines the monopoly over the specific chemical entity.
-
Use Claims:
Cover the use of the compound in treating specific conditions or diseases. This provides protection for a novel medical application, which is crucial for therapeutic patents.
-
Process Claims:
Encompass methods of synthesizing the compound or administering it, facilitating process protection alongside the compound itself.
-
Formulation Claims:
Define specific pharmaceutical formulations, such as tablets, capsules, or injectable forms, often encompassing excipients or delivery mechanisms that enhance stability or bioavailability.
Analysis of the actual claims (found through KIPO databases or patent documents) indicates whether they possess broad coverage or are narrowly tailored. For example, a claim covering a chemical core with minimal limitations offers broader protection but may face more prior art challenges. Conversely, narrow claims—such as specific substituents—limit scope but may be more defensible.
3. Patentability Criteria and Claim Strength
Korean patent law requires that claims demonstrate novelty, inventive step, and industrial applicability.
- Novelty: The compound or use must not have been disclosed previously in any prior art, including existing patents, scientific literature, or prior public disclosures.
- Inventive Step: The claimed invention must not be an obvious modification of known compounds or methods to a person skilled in the art.
- Industrial Applicability: The molecule or method must have potential for industrial production and use.
Based on available data, the patent appears to meet these criteria, with claims focusing on a unique chemical entity or its specific medial application, often supported by experimental data or data demonstrating efficacy.
4. Patent Landscape Context
a. Domestic and International Patent Family
KR20110050709 appears as part of a patent family extending into PCT or other jurisdictions. This strategic expansion aims to secure patent rights across key markets such as the US, Europe, China, and Japan.
In the Korean landscape, patent filings often correlate with leading pharmaceutical R&D activities. The patent fits into the typical pattern of novel chemical entities (NCEs) protected via composition and use claims, supported by process claims.
b. Competition and Patent Clusters
The Korean patent landscape for pharmaceuticals is highly active, with numerous filings around similar target diseases or chemical classes. Key competitors include global pharmaceutical giants and innovative biotech startups. They often file “follow-on” patents to modify existing compounds, methods, or formulations, creating patent clusters around a core invention.
If KR20110050709 covers a novel core compound, subsequent patents might target specific derivatives or enhanced delivery mechanisms, creating a dense patent thicket that complicates generic entry.
c. Overlap with Related Patents
Overlap with existing patents — either domestic or international — could influence enforceability. A freedom-to-operate analysis might reveal potential minefields or areas to carve out market exclusivity.
Implications for Strategic Patent Positioning
- Broad claims related to core chemical structures can provide strong market leverage but are also vulnerable to invalidation if prior art is found.
- Narrower, method-specific claims help reinforce patent life but might limit coverage.
- Combining chemical structure protection with use and process claims strengthens overall patent portfolio resilience against challenge.
Regulatory and Legal Considerations
South Korea's patent system emphasizes compliance with the Patent Act, including strict scrutiny of inventive step and clarity. Regulatory filings around the patent’s expiration, supplemental protection certificates (SPCs), or patent term extensions can influence market exclusivity periods.
Given the typical lifecycle of pharmaceutical patents, patent KR20110050709, granted in 2011, likely faces expiration around 2031, unless extended by supplementary protections or patent term adjustments due to regulatory delays.
Conclusion and Strategic Takeaways
-
Claim Analysis: The patent’s strength hinges on the breadth of initial claims—broad chemical or use claims provide competitive advantage, but narrow claims improve robustness against invalidation. Clear claim drafting aligned with current prior art is critical.
-
Patent Landscape Position: The patent likely forms part of a dense cluster in the Korean pharmaceutical sector, emphasizing the importance of continuous innovation and patent diversification.
-
Protection Strategy: Extending patent coverage through divisional, continuation, or additional filings in other jurisdictions remains vital to maintain market exclusivity and prevent patent erosion by competitors.
-
Legal Enforceability: Vigilant monitoring of potential conflicts and patent challenges ensures strategic defensibility.
Key Takeaways
- The patent KR20110050709 offers protection primarily for a novel chemical entity or its therapeutic application, with claims that need to balance breadth and specificity to maximize enforceability.
- Effective patent positioning in South Korea requires a comprehensive understanding of the original claims, landscape, and potential for claim amendments or follow-on applications.
- Strategic filing of international counterparts can safeguard against regional patent cliffs and facilitate global commercialization.
- Continuous monitoring of prior art and competitor filings is essential to defend or expand patent rights.
- Leveraging patent rights alongside regulatory data exclusivity and market strategy amplifies overall competitive advantage.
FAQs
1. What is the main advantage of broad claims in Korean pharmaceutical patents like KR20110050709?
Broad claims provide extensive protection over a chemical class or therapeutic use, deterring competitors; however, they are more vulnerable to invalidation if prior art is cited.
2. How does the patent landscape in South Korea affect pharmaceutical innovation?
Korea’s active patent environment fosters innovation by encouraging patent filings; however, extensive patent thickets can also create barriers for generic entrants, impacting market competition.
3. Can KR20110050709 be extended beyond its standard expiry?
Yes, through mechanisms like SPCs or patent term extensions based on regulatory delays, but these are subject to specific legal requirements and limitations.
4. What strategies should patentees consider to strengthen their Korean pharmaceutical patents?
Diversify claims by including composition, method, and formulation aspects; file follow-on patents; and coordinate filings with global patent strategies.
5. How do Korea’s patent laws impact the validity of chemical compound patents?
Strict criteria for novelty, inventive step, and clarity ensure that only truly innovative compounds receive patent protection, which can be challenged through prior art disclosures or obviousness arguments.
References
[1] Korean Intellectual Property Office (KIPO) Patent Database.
[2] World Intellectual Property Organization (WIPO) PatentScope.
[3] 한국특허법원 판례 및 저작권법, South Korea Patent Law.
[4] Patent Analyst Reports on Korean Pharmaceutical Patents, 2022–2023.
